Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.

15/11/2022
/ Publications

A study by the Samsung group Korea reported the clinical outcomes of 168 patients with early stage of NSCLC treated by photon SBRT and 34 with proton SBRT...

Lung treatment with pencil beam scanner at the Texas Center of Proton Therapy

01/01/2017
/ Event
/
Pencil Beam Scanning - PBS
Proton therapy center

The Texas Center for Proton Therapy brings an advanced cancer treatment to North Texas that offers more hope to cancer patients. The 63,000-square-foot center...

Emerging Proton Therapy Indication: Lung Cancer

24/02/2023
/ Webinar
/
PT101

Joe Chang gives a presentation on using proton therapy for lung cancer. He talks about the advantages over photons, the improvements of IMPT compared to PSPT...

High-Risk Non-Small Cell Lung Cancer Treated With Active Scanning Proton Beam Radiation Therapy and Immunotherapy.

01/03/2024
/ Publications

This study reported results of PBS-PT (60 GyRBE in 30 fractions) and immunotherapy for 29 patients with locally advanced (stage IIB to IIIC, 90%) high-risk...

Definitive intensity modulated proton re-irradiation for lung cancer in the immunotherapy era.

01/03/2024
/ Publications

This study reported results in 22 patients with recurrent NSCLC received IMPT reirradiation to a total mean dose of 60GyE. The first course of radiation was 60...

Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.

01/03/2024
/ Publications

This report presented the results of patients with non-CNS malignancies treated in the UK proton overseas program. Four hundred and ninety-five patients were...

Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.

28/03/2024
/ Publications
/
IMPT
IMRT
Toxicity

This study reported the incidence of lymphopenia in 271 stage III NSCLC patients treated with IMPT (n=71) vs IMRT (n=200) and concurrent chemotherapy. The...

Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.

06/05/2024
/ Publications
/
Survival
Quality of life
Toxicity

This study from Japan reported clinical outcomes of 43 patient with operable stage IA or IB NSCLC treated with a dose of 66 GyRBE in 10 fractions for peripheral...

Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.

06/05/2024
/ Publications
/
Toxicity

This study by the Samsung group, Korea, reported clinical outcomes of 27 patients with inoperable early stage NSCLC treated by protons to a total dose of 64...

FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.

06/05/2024
/ Publications
/
FLASH Therapy

This is a trial protocol of FAST-02. This trial includes 10 patients with 1-3 painful bone metastases in the thorax, excluding bone metastases in the spine...